Neuroplast SRL
Neuroplast reported total assets of €1.60m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of Neuroplast shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +83 % Total assets +551 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Neuroplast's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Neuroplast's financial analysis
- Solvency12.5%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Neuroplast
Neuroplast's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0807.910.723
- VAT number
- BE0807910723
- Peppol
- Registered · 0208:0807910723 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Nov 2008
- Registered office
- 7000 Mons
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Neuroplast (SRL) has been based in Mons since 2008, active in: medical specialists activities. For 2025, it reports a net loss of 231 € and equity of 199,460 €; its revenue is not published. Its solvency stands at 12.5%, below the median of its sector (65.0%).
Companies similar to Neuroplast
Companies in the same business, of comparable size and area, outside its group.
- DR. Bijnens Eric Medical specialists activities Alken · balance sheet €1.61m
- Dokter Francis Verjans Medical specialists activities Tongeren · balance sheet €1.60m
- ASPR Medical specialists activities Hechtel-Eksel · balance sheet €1.60m
- Bmol Medical specialists activities Hasselt · balance sheet €1.60m
- DR. Kiekens Medical specialists activities Schoten · balance sheet €1.60m
- Lagumed Medical specialists activities Rixensart · balance sheet €1.60m
- Gubin DE Grave Medical specialists activities Mouscron · balance sheet €1.59m
- Cardio Care Medical specialists activities Yvoir · balance sheet €1.59m
Frequently asked questions about Neuroplast
What is the revenue of Neuroplast?
Neuroplast files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Neuroplast?
In Belgium, the VAT number is the company number prefixed with BE: BE0807910723 for Neuroplast, if the company is VAT-registered. Its company number (CBE) is 0807.910.723.
Where is the registered office of Neuroplast?
According to the CBE register, the registered office of Neuroplast is in 7000 Mons.
What is the equity of Neuroplast?
At the close of the 2025 financial year, the equity of Neuroplast amounts to 199,460 €, a solvency of 12.5% of total assets.
Who manages Neuroplast?
The register lists 2 active mandates at Neuroplast. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Neuroplast
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →